Showing 1 - 9 results of 9 for search '"mdr-tb"', query time: 0.04s Refine Results
  1. 1
    The TB burden in East Java, Indonesia, post-COVID-19

    The TB burden in East Java, Indonesia, post-COVID-19 by S. Palupi, I. Pambudi, T.T. Pakasi, S. Sulistyo, K.K.K. Htet, V. Chongsuvivatwong

    Published 2024-08-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region

    Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region by G.B. Migliori, O. Korotych, J. Achar, A. Ciobanu, G. Dravniece, M. Germanovych, E. Gurbanova, A. Hovhannesyan, N. Khachatryan, L. Kuksa, N. Lomtadze, M.L. Rich, A. Skrahina, A. Yedilbayev

    Published 2024-03-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023

    Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023 by K. Bennani, M. van den Boom, M.G. ElMedrek, Y. Hutin

    Published 2024-09-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Theoretical assessment of the relative incidences of sensitive andresistant tuberculosis epidemic in presence of drug treatment

    Theoretical assessment of the relative incidences of sensitive andresistant tuberculosis epidemic in presence of drug treatment by Silvia Martorano Raimundo, Hyun Mo Yang, Ezio Venturino

    Published 2014-02-01
    Subjects: “…mdr-tb…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland

    The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland by A. Nowinski, E. Augustynowicz-Kopeć, J. Garnczarek, A. Halicka, M. Koszela, W. Litwiniuk, D. Maj, I. Mazur, J. Niestrój-Ostrowska, R. Podlasin, A. Regulska, M. Wielopolska, J. Wyrwiński, S. Wesołowski, M. Korzeniewska-Koseła

    Published 2025-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?

    Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens? by E. Pontali, M. Raviglione

    Published 2024-11-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB

    A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB by A. Vasquez, C. Mitnick, A.U. Nyaruhirira, C-Y. Chiang, C.R. Horsburgh

    Published 2024-07-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Real-life use of delamanid: results from the European post-authorisation safety study

    Real-life use of delamanid: results from the European post-authorisation safety study by N. Schönfeld, L. Barkane, I. Davoliene, M. Danilovits, S. Miliauskas, F. Ader, O.M. Kon, C. Lange, A. Duvignaud, M. Heiss-Neumann, N. Hittel, N. Lazarević, I. Knebel, A. Martin, B. Eschenbach, E. van Heumen, V. George

    Published 2024-06-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Assessment of Rifampicin Resistance in Presumptive Tuberculosis Cases at Dadeldhura Hospital of Sudurpaschim Province of Nepal

    Assessment of Rifampicin Resistance in Presumptive Tuberculosis Cases at Dadeldhura Hospital of Sudurpaschim Province of Nepal by Madan Singh Bohara

    Published 2025-02-01
    Subjects: “…Epidemiological analysis, Multidrug-resistant tuberculosis (MDR-TB), Presumptive case, Resistance patterns, Dadeldhura hospital, Mycobacterium tuberculosis, GeneXpertMTB/RIF…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: